Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 7 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 19, 2025 Filed Nov 21, 2025 21:13 UTC |
Smith Gregory LEVP Global Ops & Supply Chain
|
SaleOrdinary Shares | 825 | $102.04 | $84,183.00 |
DisclosureSEC source: 0001533098-25-000005 · wk-form4_1763759581.xml · nonDerivative · entry 4 Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,068 Read SEC document |
| November 19, 2025 Filed Nov 21, 2025 21:13 UTC |
Smith Gregory LEVP Global Ops & Supply Chain
|
SaleOrdinary Shares | 1,995 | $102.03 | $203,549.85 |
DisclosureSEC source: 0001533098-25-000005 · wk-form4_1763759581.xml · nonDerivative · entry 3 Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,893 Read SEC document |
| November 19, 2025 Filed Nov 21, 2025 21:13 UTC |
Smith Gregory LEVP Global Ops & Supply Chain
|
SaleOrdinary Shares | 1,942 | $101.99 | $198,064.58 |
DisclosureSEC source: 0001533098-25-000005 · wk-form4_1763759581.xml · nonDerivative · entry 2 Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,888 Read SEC document |
| November 19, 2025 Filed Nov 21, 2025 21:13 UTC |
Smith Gregory LEVP Global Ops & Supply Chain
|
SaleOrdinary Shares | 24,186 | $101.93 | $2,465,278.98 |
DisclosureSEC source: 0001533098-25-000005 · wk-form4_1763759581.xml · nonDerivative · entry 1 Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,830 F1 · balance_after: Includes 323 shares acquired through dividend reinvestment and 96 shares acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person. Read SEC document |
| September 03, 2025 Filed Sep 5, 2025 20:18 UTC |
KIIL HARRY SKIPEVP & President Cardiovascular
|
SaleOrdinary Shares | 200 | $91.59 | $18,318.00 |
DisclosureSEC source: 0001613103-25-000165 · wk-form4_1757103490.xml · nonDerivative · entry 2 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,615 Read SEC document |
| September 03, 2025 Filed Sep 5, 2025 20:18 UTC |
KIIL HARRY SKIPEVP & President Cardiovascular
|
SaleOrdinary Shares | 8,405 | $91.58 | $769,729.90 |
DisclosureSEC source: 0001613103-25-000165 · wk-form4_1757103490.xml · nonDerivative · entry 1 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,815 Read SEC document |
| August 25, 2025 Filed Aug 25, 2025 21:18 UTC |
Jellison William RDirector
|
PurchaseOrdinary Shares | 2,500 | $92.37 | $230,925.00 |
DisclosureSEC source: 0001613103-25-000157 · wk-form4_1756156682.xml · nonDerivative · entry 2 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 F1 · balance_after: Shares are held in joint account with spouse. Read SEC document |
| August 22, 2025 Filed Aug 25, 2025 21:18 UTC |
Jellison William RDirector
|
PurchaseOrdinary Shares | 2,500 | $92.73 | $231,825.00 |
DisclosureSEC source: 0001613103-25-000157 · wk-form4_1756156682.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500 Read SEC document |
| August 20, 2025 Filed Aug 21, 2025 20:22 UTC |
Marinaro MichaelEVP, Pres MedSurg and Americas
|
Tax withholdingOrdinary Shares | 1,052 | $93.22 | $98,067.44 |
DisclosureSEC source: 0001613103-25-000147 · wk-form4_1755807725.xml · nonDerivative · entry 1 Marinaro Michael · CIK 0001984186 · EVP, Pres MedSurg and Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,939 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:21 UTC |
Walter Matthew R.SVP, Chief HR Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 963 | $0.00 Strike: $78.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000134 · wk-form4_1754338899.xml · derivative · entry 7 Walter Matthew R. · CIK 0002028475 · SVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 963 shares Expires 2025-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:21 UTC |
Walter Matthew R.SVP, Chief HR Officer
|
Exercise / conversionPerformance Share Unit · Derivative | 2,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000134 · wk-form4_1754338899.xml · derivative · entry 6 Walter Matthew R. · CIK 0002028475 · SVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,179 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F5 · derivative.exercise_date: The performance share units vested on August 1, 2025. F5 · derivative.expiration_date: The performance share units vested on August 1, 2025. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:21 UTC |
Walter Matthew R.SVP, Chief HR Officer
|
Tax withholdingOrdinary Shares | 879 | $89.34 | $78,529.86 |
DisclosureSEC source: 0001613103-25-000134 · wk-form4_1754338899.xml · nonDerivative · entry 5 Walter Matthew R. · CIK 0002028475 · SVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,857 Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:21 UTC |
Walter Matthew R.SVP, Chief HR Officer
|
Exercise / conversionOrdinary Shares | 963 | $78.00 | $75,114.00 |
DisclosureSEC source: 0001613103-25-000134 · wk-form4_1754338899.xml · nonDerivative · entry 4 Walter Matthew R. · CIK 0002028475 · SVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,736 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:21 UTC |
Walter Matthew R.SVP, Chief HR Officer
|
Tax withholdingOrdinary Shares | 364 | $89.34 | $32,519.76 |
DisclosureSEC source: 0001613103-25-000134 · wk-form4_1754338899.xml · nonDerivative · entry 3 Walter Matthew R. · CIK 0002028475 · SVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,773 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:21 UTC |
Walter Matthew R.SVP, Chief HR Officer
|
Tax withholdingOrdinary Shares | 667 | $89.34 | $59,589.78 |
DisclosureSEC source: 0001613103-25-000134 · wk-form4_1754338899.xml · nonDerivative · entry 2 Walter Matthew R. · CIK 0002028475 · SVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,137 F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 1, 2025. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:21 UTC |
Walter Matthew R.SVP, Chief HR Officer
|
Exercise / conversionOrdinary Shares | 2,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000134 · wk-form4_1754338899.xml · nonDerivative · entry 1 Walter Matthew R. · CIK 0002028475 · SVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,804 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 1, 2022 and earned dividend equivalents. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:20 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
Exercise / conversionPerformance Share Units · Derivative | 15,249 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000133 · wk-form4_1754338822.xml · derivative · entry 4 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Unit · 15,249 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F5 · derivative.exercise_date: The performance share units vested on August 1, 2025. F5 · derivative.expiration_date: The performance share units vested on August 1, 2025. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:20 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
Tax withholdingOrdinary Shares | 3,850 | $89.34 | $343,959.00 |
DisclosureSEC source: 0001613103-25-000133 · wk-form4_1754338822.xml · nonDerivative · entry 3 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,937 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:20 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
Tax withholdingOrdinary Shares | 7,744 | $89.34 | $691,848.96 |
DisclosureSEC source: 0001613103-25-000133 · wk-form4_1754338822.xml · nonDerivative · entry 2 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,787 F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 1, 2025. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:20 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
Exercise / conversionOrdinary Shares | 15,249 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000133 · wk-form4_1754338822.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 1, 2022 and earned dividend equivalents. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:19 UTC |
Smith Gregory LEVP Global Ops & Supply Chain
|
Exercise / conversionPerformance Share Units · Derivative | 11,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000132 · wk-form4_1754338765.xml · derivative · entry 4 Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Units · 11,328 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F5 · derivative.exercise_date: The performance share units vested on August 1, 2025. F5 · derivative.expiration_date: The performance share units vested on August 1, 2025. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:19 UTC |
Smith Gregory LEVP Global Ops & Supply Chain
|
Tax withholdingOrdinary Shares | 2,656 | $89.34 | $237,287.04 |
DisclosureSEC source: 0001613103-25-000132 · wk-form4_1754338765.xml · nonDerivative · entry 3 Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,957 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:19 UTC |
Smith Gregory LEVP Global Ops & Supply Chain
|
Tax withholdingOrdinary Shares | 4,458 | $89.34 | $398,277.72 |
DisclosureSEC source: 0001613103-25-000132 · wk-form4_1754338765.xml · nonDerivative · entry 2 Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,613 F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 1, 2025. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:19 UTC |
Smith Gregory LEVP Global Ops & Supply Chain
|
Exercise / conversionOrdinary Shares | 11,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000132 · wk-form4_1754338765.xml · nonDerivative · entry 1 Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 1, 2022 and earned dividend equivalents. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:18 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 40,600 | $0.00 Strike: $78.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000131 · wk-form4_1754338722.xml · derivative · entry 7 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 40,600 shares Expires 2025-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:18 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
Exercise / conversionPerformance Share Units · Derivative | 57,724 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000131 · wk-form4_1754338722.xml · derivative · entry 6 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Unit · 57,724 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F5 · derivative.exercise_date: The performance share units vested on August 1, 2025. F5 · derivative.expiration_date: The performance share units vested on August 1, 2025. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:18 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
Tax withholdingOrdinary Shares | 37,798 | $89.34 | $3,376,873.32 |
DisclosureSEC source: 0001613103-25-000131 · wk-form4_1754338722.xml · nonDerivative · entry 5 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 247,125 Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:18 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
Exercise / conversionOrdinary Shares | 40,600 | $78.00 | $3,166,800.00 |
DisclosureSEC source: 0001613103-25-000131 · wk-form4_1754338722.xml · nonDerivative · entry 4 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 284,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:18 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
Tax withholdingOrdinary Shares | 13,054 | $89.34 | $1,166,244.36 |
DisclosureSEC source: 0001613103-25-000131 · wk-form4_1754338722.xml · nonDerivative · entry 3 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,323 F3 · shares: Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:18 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
Tax withholdingOrdinary Shares | 26,323 | $89.34 | $2,351,696.82 |
DisclosureSEC source: 0001613103-25-000131 · wk-form4_1754338722.xml · nonDerivative · entry 2 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 257,377 F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 1, 2025. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:18 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
Exercise / conversionOrdinary Shares | 57,724 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000131 · wk-form4_1754338722.xml · nonDerivative · entry 1 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 283,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 1, 2022 and earned dividend equivalents. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:17 UTC |
Marinaro MichaelEVP, Pres MedSurg and Americas
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,126 | $0.00 Strike: $78.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000130 · wk-form4_1754338653.xml · derivative · entry 7 Marinaro Michael · CIK 0001984186 · EVP, Pres MedSurg and Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,126 shares Expires 2025-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:17 UTC |
Marinaro MichaelEVP, Pres MedSurg and Americas
|
Exercise / conversionPerformance Share Unit · Derivative | 6,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000130 · wk-form4_1754338653.xml · derivative · entry 6 Marinaro Michael · CIK 0001984186 · EVP, Pres MedSurg and Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Units · 6,535 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F5 · derivative.exercise_date: The performance share units vested on August 1, 2025. F5 · derivative.expiration_date: The performance share units vested on August 1, 2025. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:17 UTC |
Marinaro MichaelEVP, Pres MedSurg and Americas
|
Tax withholdingOrdinary Shares | 2,864 | $89.34 | $255,869.76 |
DisclosureSEC source: 0001613103-25-000130 · wk-form4_1754338653.xml · nonDerivative · entry 5 Marinaro Michael · CIK 0001984186 · EVP, Pres MedSurg and Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,991 Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:17 UTC |
Marinaro MichaelEVP, Pres MedSurg and Americas
|
Exercise / conversionOrdinary Shares | 3,126 | $78.00 | $243,828.00 |
DisclosureSEC source: 0001613103-25-000130 · wk-form4_1754338653.xml · nonDerivative · entry 4 Marinaro Michael · CIK 0001984186 · EVP, Pres MedSurg and Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,855 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:17 UTC |
Marinaro MichaelEVP, Pres MedSurg and Americas
|
Tax withholdingOrdinary Shares | 1,741 | $89.34 | $155,540.94 |
DisclosureSEC source: 0001613103-25-000130 · wk-form4_1754338653.xml · nonDerivative · entry 3 Marinaro Michael · CIK 0001984186 · EVP, Pres MedSurg and Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,729 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:17 UTC |
Marinaro MichaelEVP, Pres MedSurg and Americas
|
Tax withholdingOrdinary Shares | 3,158 | $89.34 | $282,135.72 |
DisclosureSEC source: 0001613103-25-000130 · wk-form4_1754338653.xml · nonDerivative · entry 2 Marinaro Michael · CIK 0001984186 · EVP, Pres MedSurg and Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,470 F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 1, 2025. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:17 UTC |
Marinaro MichaelEVP, Pres MedSurg and Americas
|
Exercise / conversionOrdinary Shares | 6,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000130 · wk-form4_1754338653.xml · nonDerivative · entry 1 Marinaro Michael · CIK 0001984186 · EVP, Pres MedSurg and Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,628 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 1, 2022 and earned dividend equivalents. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:16 UTC |
KIIL HARRY SKIPEVP & President Cardiovascular
|
Exercise / conversionPerformance Share Unit · Derivative | 10,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000129 · wk-form4_1754338594.xml · derivative · entry 4 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 10,457 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F5 · derivative.exercise_date: The performance share units vested on August 1, 2025. F5 · derivative.expiration_date: The performance share units vested on August 1, 2025. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:16 UTC |
KIIL HARRY SKIPEVP & President Cardiovascular
|
Tax withholdingOrdinary Shares | 2,896 | $89.34 | $258,728.64 |
DisclosureSEC source: 0001613103-25-000129 · wk-form4_1754338594.xml · nonDerivative · entry 3 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,220 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:16 UTC |
KIIL HARRY SKIPEVP & President Cardiovascular
|
Tax withholdingOrdinary Shares | 4,659 | $89.34 | $416,235.06 |
DisclosureSEC source: 0001613103-25-000129 · wk-form4_1754338594.xml · nonDerivative · entry 2 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,116 F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 1, 2025. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:16 UTC |
KIIL HARRY SKIPEVP & President Cardiovascular
|
Exercise / conversionOrdinary Shares | 10,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000129 · wk-form4_1754338594.xml · nonDerivative · entry 1 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 1, 2022 and earned dividend equivalents. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:15 UTC |
Blomquist Denise L.Chief Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 214 | $0.00 Strike: $78.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000128 · wk-form4_1754338524.xml · derivative · entry 10 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 214 shares Expires 2025-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:15 UTC |
Blomquist Denise L.Chief Accounting Officer
|
Exercise / conversionPerformance Share Unit · Derivative | 58 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000128 · wk-form4_1754338524.xml · derivative · entry 9 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 58 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F6 · derivative.exercise_date: The performance share units vested on August 1, 2025. F6 · derivative.expiration_date: The performance share units vested on August 1, 2025. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:15 UTC |
Blomquist Denise L.Chief Accounting Officer
|
Exercise / conversionPerformance Share Unit · Derivative | 246 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000128 · wk-form4_1754338524.xml · derivative · entry 8 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 246 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F6 · derivative.exercise_date: The performance share units vested on August 1, 2025. F6 · derivative.expiration_date: The performance share units vested on August 1, 2025. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:15 UTC |
Blomquist Denise L.Chief Accounting Officer
|
Tax withholdingOrdinary Shares | 196 | $89.34 | $17,510.64 |
DisclosureSEC source: 0001613103-25-000128 · wk-form4_1754338524.xml · nonDerivative · entry 7 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,428 Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:15 UTC |
Blomquist Denise L.Chief Accounting Officer
|
Exercise / conversionOrdinary Shares | 214 | $78.00 | $16,692.00 |
DisclosureSEC source: 0001613103-25-000128 · wk-form4_1754338524.xml · nonDerivative · entry 6 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:15 UTC |
Blomquist Denise L.Chief Accounting Officer
|
Tax withholdingOrdinary Shares | 204 | $89.34 | $18,225.36 |
DisclosureSEC source: 0001613103-25-000128 · wk-form4_1754338524.xml · nonDerivative · entry 5 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,410 F4 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:15 UTC |
Blomquist Denise L.Chief Accounting Officer
|
Tax withholdingOrdinary Shares | 22 | $89.34 | $1,965.48 |
DisclosureSEC source: 0001613103-25-000128 · wk-form4_1754338524.xml · nonDerivative · entry 4 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,614 F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 1, 2025. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:15 UTC |
Blomquist Denise L.Chief Accounting Officer
|
Exercise / conversionOrdinary Shares | 58 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000128 · wk-form4_1754338524.xml · nonDerivative · entry 3 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,636 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on October 31, 2022 and earned dividend equivalents. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.